U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108933) titled 'Scheduled Autologous PRP Guided Injection in the Maxillary Bony Defects' on July 31.
Brief Summary: Scheduled autologous platelet-rich plasma guided injection is done in critical-sized maxillary bony defects after surgical excision of non- malignant lesions.
Study Start Date: Aug. 15, 2023
Study Type: INTERVENTIONAL
Condition:
Bony Defect
Intervention:
BIOLOGICAL: Autologous platelet-rich plasma
Guided injection of PRP in bony cavities of maxilla after surgical excision of non-malignant tumors.
Recruitment Status: COMPLETED
Sponsor: Horus University
Information provided by (Responsible Party): Eman Abdel Salam Yousef, Horus...